ARTICLE | Financial News
With $55 series D, Seer plans to bring unbiased proteomics to the market
December 17, 2019 9:08 PM UTC
Updated on Dec 17, 2019 at 10:59 PM UTC
Seer raised $55 million in an oversubscribed series D round led by Israeli investor aMoon Fund -- a financial move the company thinks will make unbiased, high-throughput proteomics a commercial reality.
T. Rowe Price funds and other undisclosed new investors joined existing investors Maverick Ventures, Invus, Wing VC and Aju IB in the round, which brings the company’s total venture funding to $109 million since its 2017 launch. ...